Real Medical Tricorder - ViATOM Checkme

Hump Day check-up.  Bones, check this one out.



Smart devices have come a long way.

The Viatom CheckMe has the following functions. This card-sized device while strictly speaking is not wearable, it provides a near 'tricorder' solution.

Supports both cable and cable-free operation

500 Hz sampling rate and wide bandwidth

30/60/90s of full disclosure waveform can be replayed

A Professional ECG algorithm is able to provide
not only Heart Rate but also QRS duration, ST
segment, and rhythm analysis

Supports both cable and cable-free operation

Built-in SpO2 sensor supports cable-free
operation

External soft-cover SpO2 sensor is available

External SpO2 ring sensor is available

External disposable SpO2 sensor is available

Oxygen saturation, pulse rate, and pulse strength are available

*****************************************************************************

In addition to this 'carry', wearable sensors have exploded from the simple "Pebble" smartwatch to "Fitbit" now owned by Alphabet (ne Google), Apple's 4th generation smartwatch and a multitude of  $ 99 lookalikes and wannabees (that are most likely built in the same Chinese factories as Apple. Don't forget Samsung Gear and other  Androgenous offerings.

Most of these offer Bluetooth connectivity to either iPhone, or Android phones.

This is a very rapidly developing niche, what is good this year will probably be obsolete in six months.  Some of these devices have the stamp of approval from the Food and Drug Administration. If so the package will say 'FDA approved"

Here are a few videos graphically displaying a number of Android and Apple Watches. If possible find a place where you can physically examine and try on the watch. There are many determinants of what will suit you.

1. Size
2. Weight
3 Color
4. Watchband material (soft, hard, metallic)
5. Fit and wearability (is it light, bulky
6. Screen visibility (some are auto-adjusting to light levels, and some screens are difficult to read due to reflectivity.
7. Battery life, and time to charge. There are some highly variabilities in the group, including wireless charging
8. Decide if you want GPS, Vital sign tracking, Cell coverage, messaging, Some watches offer downloadable apps much like your smartphone.
9. Talk to your friends and experts at electronic stores.
10. Use Google and Amazon to research the web.
11. Visit Techcrunch.com  Gizmodo.com

Sony's upcoming health platform is an easy-to-implement wearable for remote monitoring companies

Compared to Samsung, Microsoft, Apple or several other big-name electronics companies, Sony has had a fairly limited presence in the realm of digital health. To carve out its niche, Stromberg said that the mSafety platform focuses on network Sony’s technical and design strengths while leaving the particulars of health data monitoring and interpretation to its clients. 

Sony is also looking to establish itself as a long-term partner to young digital health and remote monitoring companies. Stromberg said the company is committing to multi-year support for any devices it’s putting out the door — an especially pertinent selling point in the realm of medical devices — and hopes that its reputation as an established hardware manufacturer will win over new partners. 

There is a great untapped market developing for Clinical studies using wearables and/or remote monitoring.  

Novartis, Otsuka, Pfizer, Sanofi commit to new trials on Verily's digital research platform

Verily smartwatch from Alphabet comes to the market as an FDA 510K approved device. This because it will be used for hard medical science and pharmaceutical research.

Alphabet company, today announced a new Project Baseline initiative, the Baseline Health System Consortium, comprised of Verily, Duke University Health System, Vanderbilt University Medical Center, University of Mississippi Medical Center, Mayo Clinic, Regional Health in South Dakota and the University of Pittsburgh. The strategic collaboration will identify and develop solutions to significant challenges in clinical research, including making research more accessible and engaging for patients, clinicians, researchers and research sponsors alike.  Many users will be enabled by researchers themselves as a necessity to carry out their clinical trials with patients that are widely dispersed geographically.

The Very Best Smartwatches of 2019

Apple Smart Watch Video

Fitbit Video

The Best Android Smartwatches

How Congress Can Make Real Progress on Drug Prices

Doug Badger

Visiting Fellow

Doug Badger is a Visiting Fellow in Domestic Policy Studies at the Heritage Foundation.

The House of Representatives is scheduled to vote this week on H.R. 3, the Lower Drug Costs Now Act, which would impose federal price controls on prescription medicines. The bill would limit Americans’ access to lifesaving therapies, impede the development of new treatments for deadly and debilitating diseases, and inflict harm that vastly exceeds the budgetary savings it promises.

Congress should reject the policies of H.R. 3 and pursue drug-pricing reforms that encourage innovation. Specifically, Congress should reform Medicare prescription drug payment programs and practices that prevent affordable generic medicines from coming to market. Such reforms include restructuring the Medicare Part D program to protect seniors from high out-of-pocket drug spending and refining federal laws that brand-name manufacturers are exploiting to prevent competition from generics.

These proposals enjoy overwhelming support among both parties in the House and Senate and could be signed into law by the President. All proposals are included in an alternative bill (H.R. 19) released by House Republicans on December 6.1

H.R. 19, The Lower Costs, More Cures Act, section-by-section summary released by House Republicans, December 6, 2019. H.R. 19, as outlined in this document, contains many proposals approved with bipartisan votes by the Senate HELP Committee (S. 1895, The Lower Health Care Costs Act) and the Senate Finance Committee (S. 2543, The Prescription Drug Pricing Reduction Act).

 Acting on these reforms would provide relief from high prescription drug prices, while fostering continued medical innovation that will cure diseases, lengthen life expectancy, and improve quality of life.

Get exclusive insider information from Heritage experts delivered straight to your inbox each week. Subscribe to The Agenda >>

H.R. 3: The Wrong Path

The Lower Drug Costs Now Act would reduce drug prices by government fiat, jeopardizing the quality of health care that Americans deserve.

What is worse is that H.R. 3 will not reduce drug prices at all because it will not become law. The House vote on the measure is expected to split largely along party lines, the bill lacks support in the Senate, and it is expected to face a veto threat from President Donald Trump. If Congress cannot move beyond the flawed and divisive H.R. 3 and toward effective reforms, it will adjourn next year having done nothing about drug prices.

Drug-pricing reform need not fall victim to partisan squabbling. There is broad bipartisan support for proposals to reduce prescription drug prices. Democrats and Republicans have reached a rare consensus on this contentious issue, backing reforms to Medicare prescription drug coverage and supporting a ban on practices that impede the entry of affordable generic drugs into the marketplace.

By shunning these broad-based reforms in favor of a vote on H.R. 3, House leaders have chosen partisan posturing over bipartisan progress on drug prices.

A better path is needed.

 Table 1 compares the proposals with the current law.

How Congress Can Make Real Progress

Making Medicines Affordable for Seniors: Reforms to Medicare Payment Practices. The federal government, through Medicare, helps seniors and people with disabilities to access prescription drugs via two programs: Medicare Part D and Medicare Part B. Both programs need reform in order to address policies that provide flawed financial incentives to drug makers and insurance companies that are driving up prescription drug costs.

Part D Restructuring. There is a broad consensus on the need to reform Medicare prescription drug coverage. Members of both parties agree that the Medicare Part D benefit, which was created in 2003, requires restructuring.

Under Medicare Part D, drug prices are set through negotiations between private pharmacy benefit managers and drug manufacturers without government involvement. Competing prescription drug plans sponsor insurance policies that cover drugs and set their premiums. The government subsidizes these premiums at fixed rates. Prescription drug plans compete for seniors’ business based on quality and price. Seniors can choose the plan that provides them the best value, covering the medicines they take at the most affordable prices.

Consumer choice and competition have made Part D the rarest of government programs: one in which spending has not spiraled out of control. In fact, government actuaries report that federal general revenue spending on the program was $67.8 billion in 2018. That is less than the amount that the government spent on Part D in 2015 ($68.4 billion).2

Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplemental Medical Insurance Trust Funds, The Boards of Trustees, Federal Hospital Insurance and Federal Supplemental Medical Insurance Trust Funds, April 22, 2019, Table III.D3, p. 103.

Over that same period, government spending on Medicare Part A (hospital inpatient benefits) increased by 10.5 percent (from $279 billion to $308 billion),3

Ibid., Table III.B4, p. 52.

While general revenue spending on Part B (physician and other outpatient benefits) grew by 24.2 percent (from $203.9 billion to $253.2 billion).4

Ibid., Table III.C4, p. 85.

The Part D program has also resulted in reduced spending elsewhere in the Medicare program by making drug therapies broadly accessible to seniors. Multiple studies have found that these therapies help to keep beneficiaries out of hospital beds and emergency rooms, reducing Medicare spending on hospitals and doctors.

For example, the Congressional Budget Office (CBO) estimates that a 1 percent increase in prescriptions filled by Medicare beneficiaries reduces spending on medical services by 0.2 percent.5

Congressional Budget Office, “Offsetting Effects of Prescription Drug Use on Medicare’s Spending for Medical Services,” November 2012, p. 1, https://www.cbo.gov/sites/default/files/112th-congress-2011-2012/reports/MedicalOffsets_One-col.pdf (accessed December 9, 2019).

 Applying the CBO methodology, Chris Pope of the Manhattan Institute estimated that an extra $100 in prescription drug use by Medicare beneficiaries can be expected to reduce the program’s spending on other medical services by $95, while delivering better outcomes.6

Chris Pope, “Issues 2020: Drug Spending Is Reducing Health Care Costs,” Manhattan Institute, November 6, 2019, p. 3, https://www.manhattan-institute.org/issues-2020-drug-prices-account-for-minimal-healthcare-spending (accessed December 9, 2019).

Relying on different economic assumptions, a December 2016 study by economist Robert J. Shapiro found that the Part D program had produced net Medicare savings of $679.3 billion between 2006 and 2014.7

Robert J. Shapiro, “The Value of the Medicare Part D Program for its Beneficiaries and the Medicare System,” Progressive Policy Institute, December 2016, p. 5, https://www.progressivepolicy.org/wp-content/uploads/2016/12/The-Value-of-the-Medicare-Part-D-Program.pdf (accessed December 9, 2019).

The Part D program has achieved these results through competition among prescription drug plans and through a standard drug benefit that apportions costs among beneficiaries, plans, manufacturers, and the government.

The program’s complex benefit structure could nonetheless be improved. While drug plans and beneficiaries finance prescription drug spending for the vast majority of seniors, the taxpayers shoulder 80 percent of the burden of the small minority of seniors whose annual drug spending falls into the program’s catastrophic tier (annual spending that exceeds $8,140).

Although overall Part D spending growth has been quite modest, the Medicare Payment Advisory Commission (MedPAC), an advisory arm of Congress, has noted that spending in the catastrophic tier grew from 25 percent of Part D costs in 2007 to 54 percent in 2017.8

Medicare Payment Advisory Commission, “Report to the Congress: Medicare Payment Policy,” March 2019, p. xxv, http://www.medpac.gov/docs/default-source/reports/mar19_medpac_entirereport_sec.pdf (accessed December 9, 2019).

 MedPAC attributes this in part to the program’s benefit structure.

There is broad congressional support for restructuring the Part D benefit. Several proposals have emerged. While they differ in detail, they share two important features: They cap the amount that seniors spend annually on prescription drugs, and they shift financing in the catastrophic tier from taxpayers to Part D plans and drug manufacturers.9

For a detailed analysis of these various options, see Tara O’Neill Hayes, “Competing Proposals to Medicare Part D,” American Action Forum, September 23, 2019, https://www.americanactionforum.org/insight/competing-proposals-to-reform-medicare-part-d/ 

Reference:

Life, Liberty and Levin: Sally Pipes dispels myths surrounding single-payer health care proposals | Fox News Video

Health care expert discusses the Affordable Care Act, rising prescription drug costs and the Trump administration's plans for health care reform.
br />

The latest buzzword now is a single-payer health plan. Another iteration would be Medicare-for-all. Mix in with this is the Affordable Care Act ACA or Obamacare.  The ACA covers a large demographic from birth to end of life. Medicare covers the over 65 elderly, and the disabled. Disabled veterans (service-connected) are eligible for medical services at a VA facility, clinic or hospital.  Just because you are a veteran does not mean you are eligible for free VA medical services. The Indian Health Service, Department of Defense, and the Federal Employees Health Benefit Plan
The GAO and OPM report:  The Department of Defense program is Tricare,

TRICARE is a health program for:

Uniformed Service members and their families,
National Guard/Reserve members includes members of the:
Army National Guard
Army Reserve
Navy Reserve
Marine Corps Reserve
Air National Guard
Air Force Reserve
U.S. Coast Guard Reserve
 and their families,
Survivors,
Former spouses,
Medal of Honor recipients and their families, and
Others registered in the Defense Enrollment Eligibility Reporting System (DEERS).

"Federal Employees Health Benefits Program (FEHBP) enrollees can choose from a number of health plan offerings depending on where they live. From 2007 to 2015, the median number of plan offerings available in a county increased from 19 to 24. Of the 24 plan offerings in 2015, 19 were available nationwide and 5 were health maintenance organization plans offered in specific geographic areas. Yet despite more available plan offerings in recent years, enrollment has become more concentrated within the largest health insurance carrier in a county. Specifically, the median share of enrollment held by the largest carrier in a county increased from 58 percent in 2000 to 72 percent in 2015. Further, one carrier—the Blue Cross Blue Shield Association—was the largest carrier in 93 percent of counties in 2000 and 98 percent of counties in 2015."  Strictly speaking, it is not a government health insurance plan.

This list is a guideline only and patients must verify their eligibility for each plan.  Our health system in the United States is a hodge-podge disorganized system. Enrollment eligibility and benefits change each year and the period for enrollment is for a short two month period from October through early December.  It is not patient-centric, it's organization is centered around expediency for payors and government entities.

Details are available at the links in the article.






Sally Pipes dispels myths surrounding single-payer health care proposals | Fox News Video

Health Mishaps of the Last Century – What were the Worst?

We had ‘asthma cigarettes’ or burning powders which contained stramonium or nitrates that nullified any benefit due to the deleterious effect of the smoke itself [1,2] around the turn to the mid last century. Marketing at the time declared asthma cigarettes, ‘agreeable to use, certain in their effects, harmless in their action [and] safely smoked by ladies and children’. Such a recommendation today is unthinkable.

An infant feeding bottle that used a rubber tube to deliver the milk to the baby became known as the “Murder Bottle” because of the bacteria that lurked in the rubber tube. It took several decades for the bottle to be banned.

The armed serviced encouraged soldiers to smoke tobacco as a means of “settling the nerves”, though withdrawal symptoms did anything but. So many military people returned home from the wars addicted to nicotine, which often resulted in a premature demise.

The widespread use of asbestos on ships, in asbestos cement sheeting and in-ceiling insulation, was a major danger that took several decades after exposure to eventuate in asbestosis or mesothelioma, both equally devastating.

Feeding dogs with infected sheep offal allowed hydatids to take hold on the human population. 

Thalomid tablets, containing thalidomide, were a major prescribing disaster of the 1950s 

Used as an anti-nauseant and mild sedative in early pregnancy, many children were born with limbs missing. (The only saving grace was that several doctors gave these samples to their wives to use, so they also had the financial means to support their disabled children after birth)
In Australia, we still see the fallout of APC (aspirin, phenacetin, and caffeine) powders, a very popular analgesic until the 1960s. It was a staple in most Aussie households and the mantra, “A cup of tea, a Bex, and a good lie down” entered the everyday language. Later when it was discovered that phenacetin caused kidney damage this ingredient was dropped or changed to paracetamol. However, by then the mantra was synonymous as a pathway to contracting analgesic nephropathy and bladder cancer! [4]

There are countl

ess other missteps in medical history which caused more harm than good. Which stick in your mind?

References

1. https://www.australianpharmacist.com.au/the-original-puffer-2/

2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844275/

3. https://www.abc.net.au/news/health/2018-06-28/thalidomide-william-mcbride-named-birth-defect-links/9920446

4. https://onlinelibrary.wiley.com/doi/full/10.1111/1753-6405.12252

The Fascinating World of Food Scanners - The Medical Futurist

Would you like to know what is in that snack? How about your dinner plate, or the meal just served to you at the restaurant, fast food place, or the meal delivered to you from Plate, or other online food order?

Advances in technology and 'sniffer chips' can analyze biological chemicals and tell you.  This technology is not yet widely available.  However, it is coming soon Think about what it will do for health and wellness and your plans to lose 25 pounds before the holidays.

SCIO uses infrared spectrometry to identify chemical fingerprints

We strongly believe that digital health can bring healthcare into the 21st century and make patients the point-of-care.

There are two major issues. One is size because the device must be handheld to become popular. With current technology, this means engineers have to sacrifice sensitivity and accuracy in order to achieve a convenient size. The other issue is the algorithm. SCiO sends data to the cloud which then sends its calculation back to the device. But to simplify what the algorithm has to do, users need to tell the scanner specifics – like whether the sample is a portion of solid food, a liquid, or vegetable. These inconveniences are the price of keeping the scanner small.

There aren’t any promising handheld food scanners on the horizon besides these, but there is no reason to believe a solution will not arise in the coming years. The challenge is not when a workable device comes along but what we will do with the large amount of data it generates.

Big data and the Internet of things will improve nutrition
Let’s say a scanner tells me how many grams of sugar my fruit contains, or what the alcohol percentage of a drink is. So what? It won’t change my behavior and dietary habits unless I’m a dietitian and understand what the data means, and how it can be acted upon. Food scanners will need to progress similarly to wearable health trackers – move from raw data to automated analysis and smart suggestions to the user.

Learn more about the most exciting technological changes shaping healthcare! A good food scanner should accurately determine ingredients, and compare the data to my lifestyle, dietary choices, and my genomic background. Given how different we all are genetical, two people might digest the same food at a different pace. One might be allergic to an ingredient while the other is not. So far, pure luck and experience have alerted us to these differences. It should not work like that. Eating should be a conscious process where we know what we eat, and know what we should eat for optimum health. A food scanner, supported by a smart application could fill this place.

But let’s not leave out an interesting side note here, namely, incorporating genetic information into food scanners. I already have the data of my complete DNA sequence at home in a digital file. Literally, thousands of studies speak to the genetic aspects of nutrition, a field called nutrigenomics. I should be able to learn what foods and individual ingredients are bad for me. Genetic tests showed me that I’m sensitive to caffeine and process alcohol more thoroughly than most people (I’m Hungarian after all).

Nutrigenomics tries to understand how nutrition affects our metabolic pathways, and what we can do to get the most out of nutrition in a personalized way. If I’ll have the opportunity to choose another type of meat or cheese as a smartphone app suggests based on my DNA, I will enjoy the meal more and take better care of my body in the long run. With access to such data, a scanner or app could tell us what products not to buy at the grocery store, what type of food makes us more productive, sleep better, or just feel healthy. Right now we’re depending on blind luck.

Some people wonder if this wouldn’t be an overly technological world where devices, scanners, and apps tell us what to eat and do. I prefer to look at it from a different angle, from the benefits of finally knowing what we eat and what ingredients lead to positive and negative consequences. I see customization to my specific genetic background as another benefit, too.

Diabetes patients would know how many carbohydrates their food contains. But knowledge doesn’t change behavior alone, otherwise, nobody would smoke by now. Knowledge supported by gaming or technologies revealing our lifestyle choices to our family members or caregivers might do. Patients with rare genetic metabolic disorders such as phenylketonuria would know what to avoid at all cost. People with allergies could avoid dangerous meals. Having a good diet would not rely on the experience we bring with us from childhood and what we have learned since then. Instead, it could be based on informed decisions. If it means a food scanner should become a commodity in my life for this, count me in.

Tellspec is another handheld scanner device to analyze food. Here is how it works.

The developer of Tellspec is Tellspec’s CEO, Isabel Hoffmann, is the recipient of the 2018 Women in Innovation awarded by the European Institute for Innovation and Technology (EIT).

These devices can also analyze other substances besides foods. The manufacturers of both scanners offer SDKs for developing other analytic profiles.

Infrared spectroscopy has been around for a long time. Sir William Herschel was the first to recognize the existence of infrared in 1800. Interest in IR was not explored further for 80 years. During 1882-1900 several investigations were made into the IR region. Today's iteration is the result of microchips and miniaturization of the scanner, merging it with cloud-based software and algorithms which can be plugged in via software to modify the scanner's range of detection.

The author:  Gary M. Levin M.D.

The Fascinating World of Food Scanners - The Medical Futurist:

IDx-DR, the First FDA-Approved AI System, is Growing Rapidly

Screening for diabetic retinopathy has become easier to access. both for patients with diabetes, primary care providers, and specialists.  The use of artificial intelligence and image analysis using machine learning represents a major improvement for public health. It is already in use in many places.

Moderate Proliferative Diabetic Retinopathy

IDx-DR, a hybrid hardware/software artificial intelligence device is capable of diagnosing diabetic retinopathy without human intervention. The system is the first FDA-approved autonomous artificial intelligence (AI), using its software to analyze images from a retinal camera for evidence of lesions. These lesions are a sign of retinal damage that is associated with diabetes and are what physicians look for in diagnosing eye disease in diabetic patients. Recently, we took the time to check in with IDx CEO and Founder Michael Abramoff, MD, Ph.D., about how this innovative technology has fared in the past year.

IDX-DR was only in place at the University of Iowa Health Care when we spoke with Dr. Abramoff last summer, however, he notes that the technology is now implemented in over 20 locations in the country. Some of the institutions utilizing this AI technology include:

Blessing Health (Quincy Il.)
Johns Creek Primary Care. (Suwanee, GA)
Johns Hopkins
LCMC (New Orleans, LA)
University of Iowa Health Care (Iowa City, IA)

“The company has done well in developing an algorithm that can detect the possibility of early disease,” said Tim Beth, DO, Family Medicine, Blessing Health Center, in a press release. “We would be missing patients if we did not use it.”

“After I see the patient, if they qualify for it or if they don’t have an eye doctor, we do the exam and get immediate results,” he continued. “If there is any evidence of retinopathy, we refer them to an eye doctor. If there is no evidence of retinopathy, we’ll do it again next year.”

One of the unanswered questions about IDx-DR technology is whether it is improving patient outcomes. Dr. Abramoff noted that there are a number of existing studies that show early detection of diabetic retinopathy can improve patient outcomes, but it has not yet been proven in IDx-DR. To address this, IDx is conducting several studies with early partners to determine whether patients who receive a positive result from IDx-DR are actually getting to the eye care provider and receiving proper treatment. Additionally, the company recently launched at a chain of retail health clinics called CarePortMD, which has a unique care coordination model that ensures patients with positive IDX-DR exam results are transmitted to the patient’s primary care doctor and same-day or next-day appointments are made with an eye care specialist. IDx plans to expand this care coordination model to other settings to ensure patients are getting the follow-up care they need.



IDx-DR, the First FDA-Approved AI System, is Growing Rapidly - Docwire News:

More than 400 UCLA medical school students get a free education thanks to major donation - Los Angeles Times

Medical school isn’t cheap.

The median tuition was $38,119 at a public medical school, for a student paying in-state tuition, fees and health insurance during the 2018–2019 academic year. And that number, which comes from the Association of American Medical Colleges, is on the low end. The median cost for tuition, fees, and health insurance for students at private schools in that time span was more than $60,000.

A $46-million donation from entertainment billionaire David Geffen means 414 medical school students are receiving full-tuition merit scholarships

UCLA Chancellor Gene Block, left, presents an award to David Geffen in 2014. Geffen has donated more than $400 million to the university, mostly for the medical school.

(Imeh Akpanudosen / Getty Images)

The UCLA David Geffen School of Medicine announced Monday that the DreamWorks co-founder, who gave the school $100 million in 2012, has donated an additional $46 million to continue to fund merit-based scholarships so medical students do not have to take on weighty loads of debt. His UCLA donations total nearly half a billion dollars in the last two decades, much of it to the medical school.

The scholarships cover tuition and expenses, and students are told of the award when accepted to the medical school. The school expects that the $146 million will fund 414 scholarships — 20% to 30% of each class for a decade, ending with the class of 2026.

Last year, 75% of U.S. medical school graduates had accrued debt that averaged almost $200,000, according to an Assn. of American Medical Colleges Survey of graduates from 150 medical schools. For California residents, tuition and fees alone at UCLA’s four-year program cost upward of $42,000 annually.

Medical students do tend to have higher-income parents who are more likely to have college degrees, according to surveys from the Assn. of American Medical Colleges.

Geffen declined to comment on the donation via a university spokesman. The medical school bears his name after a $200-million gift in 2002, and in addition to this scholarship, he donated $100 million in 2015 to start a private school meant in part to serve the children of UCLA faculty members.

UCLA is not the only school to seek out large donations for its medical students. Last year New York University’s School of Medicine announced that it was raising $600 million from private donors to cover tuition for all students.

Most medical school students who gain acceptance have one to three schools to choose from, said Geoffrey Young, senior director of student affairs and programs for AAMC. As a former admissions committee member at three schools, including the Medical College of Georgia, he said, “If we could use scholarship money to entice someone to come to that school, I would. That’s a free market.”

Geffen was clear that he wanted to use merit-based scholarships to attract the best potential doctors to the school, said UCLA Health Sciences Vice-Chancellor Dr. John Mazziotta. Other students do have access to need-based scholarships, and Mazziotta said his ultimate goal is to start an endowment that would fund UCLA medical school for all students “forever” — an endeavor that would take upward of $1 billion, he said.

The scholarships awarded to UCLA Medical School are based on merit, not need. Not all students receive the scholarship as only about 30% of students receive the funds.

Some schools offer to fund based upon need, or geographic commitment to serve in an underserved community.

Service scholarships

Service-based scholarships funded by the federal government offer students a chance to fund virtually their entire education in exchange for a commitment to serve a certain population. Among the more popular options is the National Health Service Corps Program, which requires a year of work as a primary care doctor in an underserved region for every year of scholarship funding, with a minimum of two years of service. The military-sponsored Health Professions Scholarship Program provides a full scholarship to medical school in exchange for an obligation to serve as a military physician.

Outside scholarships

When students interview at UC Davis, they are given a written list of available outside scholarship opportunities. It is 32 pages long and is still is only the tip of the iceberg.

“In terms of…donors and agencies that sponsor students, many of these resources spring from local community goodwill,”

Check with community organizations such as county medical societies, and Rotary, Lions or Soroptimist clubs to see what type of scholarship opportunities are available.

Kaiser Permanente is offering 'free medical school' during the next five years, with a commitment to work at a Kaiser Hospital for several years

NYU Medical School Plans Free Tuition For Those Studying To Be Doctors

Students will not have a totally free ride, however. According to The Wall Street Journal, most medical students will still foot the bill for about $29,000 each year in room, board, and other living expenses. The scholarships will help 93 first-year students along with 350 already partially through the program, the Journal reports. Several students enrolled in a joint MD/Ph.D. program are already offered free tuition under a separate program. NYU also says medical school debt is "reshaping the medical profession," as graduates choose more lucrative specialized fields in medicine rather than primary care. 

Columbia School of Medicine, one of the most prestigious, has received a large grant from an alumnus, Dr. P. Roy Vagelos, 88, the former chairman of Merck & Co., and his wife, Diana, are donating $250 million to the school, $150 million of which will fund an endowment that the school projects will ultimately enable it to underwrite its student financial aid. Those students with the greatest financial need would receive full-tuition scholarships, while others would get only grants, not loans, to make up their need, the school said.

The couple also funded the construction of the Vagelos Education Center at the medical school, which is filled with high-tech classrooms and facilities. Credit...Philip Greenberg for The New York Times

The Vallejos Education Center was designed by Elizabeth Diller and Ricardo Scofidio, founders of Diller Scofidio + Renfro. Available on Amazon Kindle










More than 400 UCLA medical school students get a free education thanks to major donation - Los Angeles Times: 

Put Away The Jade Eggs And Garlic: This Doctor's 'Vagina Bible' Separates Fact From Fiction | On Point

In her funny, fact-based book, OB-GYN and New York Times columnist Dr. Jen Gunter separate myth from medicine about women’s bodies.

One of the core tenets of medicine is informed consent. We, doctors, provide information about risks and benefits and then, armed with that information, our patients make choices that work for their bodies. This only works when the information is accurate and unbiased. Finding this kind of data can be challenging, as we have quickly passed through the age of information and seem to be stalled in the age of misinformation.

Snake oil and the lure of a quick fix have been around for a long time, and so false, fantastical medical claims are nothing new. However, sorting myth from medicine is getting harder and harder.

In addition to social media feeds that constantly display medical messaging of variable quality, there are the demands of a headline-driven news cycle that constantly requires new content-even when it doesn't exist. With women's bodies, there are even more forces of misdirection at work. Pseudoscience and those who peddle it are invested in misinformation, but so is the patriarchy.

Obsessions with reproductive tract purity and cleansing date back to a time when a woman's worth was measured by her virginity and how many children she might bear. A vagina and uterus were a currency. Playing on these fears awakens something visceral. It's no wonder the words “pure,” "natural,” and “clean” are used so often to market products to women.

Much misinformation is disseminated by celebrities such as Gwyneth Paltrow, Suzanne Somers, and others.  Typically these spokespersons fit society's measures of success and/or beauty which in no way certifies them in medical matters.  Goop is a commercial company owned by Paltrow and from which she makes profit from every sale.  There is a great imbalance right there as to any credibility about her claims.

Dr. Gunter goes on to say,

"I have been in medicine for thirty-three years, and I've been a gynecologist for twenty-four of them. I've listened to a lot of women, and I know the questions they ask as well as the ones they want to ask but don't quite know-how.

The Vagina Bible is everything I want women to know about their vulvas and vaginas. It is my answer to every woman who has listened to me pass on information in the office or online and then wondered, “How did I not know this?”

Most companies do not get 'called out' for their false claims that border on outright fraud. However the State of California  took issue with some of Goop's claims,

Washington Post: "Gwyneth Paltrow’s Goop touted the ‘benefits’ of putting a jade egg in your vagina. Now it must pay." — "We need to talk about Gwyneth Paltrow's vaginal eggs. Again.

"For the uninitiated, these are the egg-shaped jade or quartz stones sold through Goop, Paltrow's new-age wellness company, and lifestyle brand. Per Goop, women are supposed to insert said eggs into their vaginas — and keep them there for varying periods of time, sometimes overnight — to 'get better connected to the power within.'

"For $66, one can buy a dark nephrite jade egg, which allegedly brings increased sexual energy and pleasure. Or, for $55, there is the 'heart-activating' rose quartz egg, for those who want more positive energy and love. Until recently, a page on Goop's website promised that the eggs would 'increase vaginal muscle tone, hormonal balance, and feminine energy in general.'

"Those claims were, well, a stretch, with no grounding in real science, according to a consumer protection lawsuit filed by state prosecutors representing 10 California counties. On Wednesday, state officials and Goop announced that they had settled the suit, with Paltrow's company agreeing to pay $145,000 in civil penalties.

"Specifically, the suit called out Goop's jade egg, its rose quartz egg and its 'Inner Judge Flower Essence Blend' as products 'whose advertised medical claims were not supported by competent and reliable science,' according to the Santa Clara County district attorney's office. For example, the flower essence blend had been marketed as a blend of essential oils that could ward off depression.

In another blog article, we will talk more about other pseudo-scientific claims for stem cell therapy, genomics, precision medicine, and other hot button topics.

Below is an NPR podcast with Dr Gunter

Transportation Equity, Health, and Aging: A Novel Approach to Healthy Longevity with Benefits Across the Life Span - National Academy of Medicine

Social Determinants of Health (SDH)

Figure 1.

Gini coefficient

One of the most neglected social determinants of health is access to adequate transportation. While housing, education, social inequality (as reflected by the Gini coefficient), and income are widely recognized as important factors of well-being, it is striking that the public health discourse on transportation has overwhelmingly emphasized the negative aspects [1]. These include crashes, injury, mortality, pollution, lack of exercise, and noise. A worthy public health emphasis on active mobility through walking and cycling may have also overshadowed the central role of transportation as driver or passenger in an automobile for the majority of the US population who do not have access to effective public transportation or who have compromised personal mobility. Recent evidence points to the negative consequences of restricted personal vehicle transportation on an individual’s independence, emotional and social well-being, and life expectancy.

The public health bias towards the negative aspects of transportation issues, particularly driving, has led to observed disengagement of physicians and other clinicians in assessing and promoting medical fitness to drive and a failure to consider the transportation needs of patients when accessing health care services [2]. For those clinicians who do address fitness to drive, few supports exist. At the federal level, a standard for fitness to drive exists only for commercial drivers (Federal Motor Carrier Safety Administration 49 CFR Part 391). At the state level, regulations vary regarding medical standards for fitness to drive and requirements for mandatory reporting of impairment. Seventeen states lack medical advisory boards to guide these regulations, and thirteen states lack internal medical units to review medical evaluations and/or need for re-examination of referred drivers [23]. States without such medical support systems rely on individual physician opinion about fitness to drive and driving impairment despite a general lack of physician knowledge of medical fitness-to-drive guidelines [3].

Lack of consistent Standards.  California DMV Guidelines. However many states do not have standards or guidelines.

It is not surprising, therefore, that there has been little dialogue between the field of health care and the main disciplines involved in transportation, such as transportation planners and engineers. However, the beginnings of a rapprochement between the fields have begun, through an emerging focus on the impact of disease and disabilities on transportation mobility and driving safety. This emerging scientific foundation should replace stereotypes, opinions, and anecdotes, and should guide evidence-based transportation counseling for older drivers, young drivers, and those with medical conditions and disabilities.

































Transportation Equity, Health, and Aging: A Novel Approach to Healthy Longevity with Benefits Across the Life Span - National Academy of Medicine: